New antibody shows promise in slowing kidney disease
Disease control
Completed
This study tested a drug called felzartamab in 54 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. The drug targets a protein on immune cells to reduce protein leakage in urine, a sign of kidney damage. Results suggest it may help control the disease…
Phase: PHASE2 • Sponsor: HI-Bio, A Biogen Company • Aim: Disease control
Last updated May 15, 2026 11:54 UTC